Published on 8 Mar 2024 on Zacks via Yahoo Finance
IGM Biosciences, Inc. (IGMS) Reports Q4 Loss, Lags Revenue Estimates
IGM Biosciences, Inc. (IGMS) came out with a quarterly loss of $1.01 per share versus the Zacks Consensus Estimate of a loss of $1.06. This compares to loss of $1.19 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 4.72%. A quarter ago, it was expected that this company would post a loss of $1.25 per share when it actually produced a loss of $1.04, delivering a surprise of 16.80%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.